Plus   Neg

Stock Alert: SCWorx Soars 160% On 2 Mln Order For COVID-19 Blood Test Units

Shares of SCWorx Corp. (WORX) surged more than 160% on Monday morning after it announced that it received order for two million COVID-19 Rapid Testing Units.

WORX is currently trading at $5.96, up $3.67 or 160.26%, on the Nasdaq.

The thinly traded nano cap company said it received a purchase order for two million COVID-19 Rapid Testing Kits from virtual healthcare network Rethink My Healthcare.

The order also has with a provision for additional orders of 2 million units a week for 23 weeks, valued at $35 million per week.

Commenting on the order, CEO Marc Schessel said, "Our substantial purchase order from Rethink My Healthcare will significantly increase the availability of rapid-test kits in the United States. Additional purchase orders currently under negotiation with certain other parties could further increase the U.S. supply of these important tests in the near term."

The COVID-19 Corona Virus IgM/IgG Rapid Test is an in-vitro diagnostic test solely for the qualitative determination of COVID-19's IgM and IgG antibodies in human whole blood, serum, plasma and fingertip blood.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT